InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
14%
T+90 mean return
-23.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MULLEN JAMES C, Chairman & CEO. Insider active across 2 companies, notably Thermo Fisher Scientific INC.. In total, 14 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €1.8m. Activity tracked since 19 May 2021. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations14 total
565 shares0Common StockSEC:0000097745-25-000059:0
339 shares0Common StockSEC:0001127602-24-016371:0
392 shares0Common StockSEC:0001127602-23-016992:0
369 shares0Common StockSEC:0001127602-22-015287:0
18,252 shares@ US$26.95480.22% mcap48.9% of flowCommon StockSEC:0001179110-22-000112
18,252 shares@ US$26.95480.22% mcap24.4% of flowCommon StockSEC:0001179110-22-000112:0
36,477 shares0Common StockSEC:0001179110-21-011223:0
36,477 shares0Common StockSEC:0001179110-21-011223
13,805 shares@ US$38.032125.6% of flowCommon StockSEC:0001179110-21-009557
13,805 shares@ US$38.03210.23% mcap25.6% of flowCommon StockSEC:0001179110-21-009557:0
36,478 shares0Common StockSEC:0001179110-21-009149:0
36,478 shares0Common StockSEC:0001179110-21-009149
438 shares0Common StockSEC:0001127602-21-017562
438 shares0Common StockSEC:0001127602-21-017562:0
14 of 14 declarations
About MULLEN JAMES C
James C. Mullen is the Chairman & CEO of Thermo Fisher Scientific Inc. and Editas Medicine, Inc. He oversees the strategic operations and overall direction of these companies. With extensive experience in the industry, Mullen is recognized for his leadership in developing innovative solutions and advanced technologies. His role also involves managing stakeholder relationships and promoting sustainable growth within his organizations.
